ECOR1 CAPITAL, LLC

Adviser information for ECOR1 CAPITAL, LLC last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Liability Company
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 21
Investment Advisory/Research 8
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 5 $5.0B
Non-Discretionary 0 $0
Total 5 $5.0B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 5 $5.0B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 40

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-100470
SEC ERA File Number 801-100470
SEC CIK Numbers 1587114
SEC CRD Numbers 167121
Legal Entity Identifier 254900G27UH5KKYMY240

Principal Office

357 TEHAMA STREET
FLOOR 3
SAN FRANCISCO
CA
United States
Monday - Friday, 8:00AM - 2:00PM
Tel: 415-754-3517, Fax: 415-952-9412

Chief Compliance Officer

SARAH MARRIOTT
COO, CCO
357 TEHAMA STREET
FLOOR 3
SAN FRANCISCO
CA
United States
Tel: 415-754-3517
Fax: 415-952-9412
(Full email address available in API data)

Regulatory Contact

N/A
N/A
N/A
N/A
Other

Industry Affiliates

BIOTECH OPPORTUNITY GP, LLC Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
ECOR1 CAPITAL FUND QUALIFIED, L.P. Hedge Fund $4,604.5M $25.0M 324
ECOR1 CAPITAL FUND, L.P. Hedge Fund $311.9M $25.0M 87
ECOR1 VENTURE OPPORTUNITY FUND, LP Venture Capital Fund $85.3M $2.0M 59

Control Persons

Name Type Entity Title Since Ownership
NODELMAN, TRUSTEE, OLEG Individual MANAGER 11/2012 > 75%
MARRIOTT, TRUSTEE, SARAH Individual MEMBER, CCO, COO 11/2012 10-25%

No. Employees, Historic

3015020192020202120222023202420259 on 8/29/201911 on 3/30/202013 on 3/30/202113 on 6/25/202115 on 3/29/202215 on 11/11/202217 on 3/29/202321 on 3/28/2024

RAUM, Historic

6B3B020192020202120222023202420251754318933 on 8/29/20191831163123 on 3/30/20202835756000 on 3/30/20212835756000 on 6/25/20214439985676 on 3/29/20224439985676 on 11/11/20224711772578 on 3/29/20235001741440 on 3/28/2024

No. Clients, Historic

105020192020202120222023202420256 on 8/29/20196 on 3/30/20206 on 3/30/20216 on 6/25/20215 on 3/29/20225 on 11/11/20225 on 3/29/20235 on 3/28/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
ACADIA PHARMACEUTICALS INC COM 22M 1M
ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR 27M 27M
ALIGOS THERAPEUTICS INC COM 2M 6M
ALLOVIR INC COM 8M 11M
ANAPTYSBIO INC COM 188M 8M
APELLIS PHARMACEUTICALS INC COM 445M 12M
ARVINAS INC COM 179M 7M
ATARA BIOTHERAPEUTICS INC COM NEW ADDED 3M 407K
ATEA PHARMACEUTICALS INC COM 18M 5M
AVIDITY BIOSCIENCES INC COM 31M 758K
BICYCLE THERAPEUTICS PLC SPONSORED ADS 18M 910K
CAREMAX INC *W EXP 06/08/202 279K 100K
CARGO THERAPEUTICS INC COM 24M 1M
CELLDEX THERAPEUTICS INC COM NEW 24M 650K
CENTESSA PHARMACEUTICALS PLC SPONSORED ADS 52M 6M
CRINETICS PHARMACEUTICALS IN COM 186M 4M
CRISPR THERAPEUTICS AG NAMEN AKT 75M 1M
DYNE THERAPEUTICS INC COM 15M 427K
EDGEWISE THERAPEUTICS INC COM 23M 1M
GALAPAGOS NV SPON ADR 143M 6M
GENERATION BIO CO COM 6M 2M
HOOKIPA PHARMA INC COM 3M 6M
IMMUNOME INC COM 47M 4M
ITEOS THERAPEUTICS INC COM 48M 3M
JANUX THERAPEUTICS INC COM 62M 1M
JAZZ PHARMACEUTICALS PLC SHS USD 108M 1M
KEROS THERAPEUTICS INC COM 9M 188K
KURA ONCOLOGY INC COM 120M 6M
KYVERNA THERAPEUTICS INC COM 3M 450K
LENZ THERAPEUTICS INC COM 21M 1M
MADRIGAL PHARMACEUTICALS INC COM 21M 75K
MERSANA THERAPEUTICS INC COM 39M 19M
MORPHIC HLDG INC COM 170M 5M
NEUMORA THERAPEUTICS INC. COM 20M 2M
NEUROGENE INC COM 46M 1M
NUVATION BIO INC *W EXP 07/07/202 3M 963K
NUVATION BIO INC COM CL A 56M 19M
ORIC PHARMACEUTICALS INC COM 24M 3M
PHARVARIS N V COM 17M 900K
PRIME MEDICINE INC COM 4M 700K
PROQR THRAPEUTICS N V SHS EURO 3M 2M
PROTHENA CORP PLC SHS 239M 12M
REPLIMUNE GROUP INC COM 8M 850K
ROCKET PHARMACEUTICALS INC COM 11M 508K
SAREPTA THERAPEUTICS INC COM 222M 1M
SURROZEN INC *W EXP 08/01/203 730K 67K
TANGO THERAPEUTICS INC COM 114M 13M
TECTONIC THERAPEUTIC INC COM ADDED 14M 849K
THIRD HARMONIC BIO INC COM 41M 3M
TSCAN THERAPEUTICS INC COM 29M 5M
VAXCYTE INC COM 23M 300K
VERVE THERAPEUTICS INC COM 6M 1M
VOYAGER THERAPEUTICS INC COM 31M 4M
XENCOR INC COM 101M 5M
ZYMEWORKS INC COM 114M 13M